Differences in the Predominance of Lysosomal and Autophagic Pathologies Between Infants and Adults With Pompe Disease: Implications for Therapy

Molecular Genetics and Metabolism - United States
doi 10.1016/j.ymgme.2010.08.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Autophagic- And Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and Shadows

Cells
2019English

Newborn Screening for Pompe Disease in Illinois: Experience With 684,290 Infants

International Journal of Neonatal Screening
Child HealthPediatricsGynecologyPerinatologyMicrobiology ObstetricsImmunology
2020English

Survival and Associated Factors in 268 Adults With Pompe Disease Prior to Treatment With Enzyme Replacement Therapy

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2011English

Correcting Neuromuscular Deficits With Gene Therapy in Pompe Disease

Annals of Neurology
Neurology
2015English

Supine Volume Drop and Diaphragmatic Function in Adults With Pompe Disease: Table 1–

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2012English

Structure of Human Lysosomal Acid Α-Glucosidase–A Guide for the Treatment of Pompe Disease

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Differences in the Stratum Corneum of Indonesian Infants and Adults

Paediatrica Indonesiana
2017English

Enzyme Replacement Therapy for Late-Onset Pompe Disease

Cochrane Database of Systematic Reviews
2018English

PHP7 Recent Developments in Pompe Disease Therapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy